Loeb Cuts, Highland Boosts Stakes In PDL Battle

Nov 5 2007 | 3:39pm ET

In response to what it says are insufficient measures taken by portfolio company PDL BioPharma, activist hedge fund Third Point has cut its stake in the company almost in half. But another activist hedge fund with similar demands has stepped up its pressure on the Fremont, Calif.-based company.

In a letter to PDL’s board, Daniel Loeb, founder of the New York-based hedge fund, said he had cut his fund’s stake from 9.7% to 5.1% “in light of your continuing refusal to provide us with a voice in the company’s affairs through a board seat.” Loeb has long sought a sale of PDL, and said he was “encouraged” by the board’s announcement it would actively seek such a sale. But he ripped Chairman Patrick Gage, who has served as interim CEO since former CEO and Loeb nemesis Mark McDade resigned this summer, saying he has “demonstrated his unsuitability” for the post.

Unfortunately for the maligned Gage and his cohorts on the board, Loeb’s retreat coincided with the advance of another activist seeking major changes at the company. Dallas-based Highland Capital Management took a 5.2% stake in PDL over the past few months, and fired off a letter in September—filed with the Securities and Exchange Commission last week—with its own set of strident demands.

Highland President Jim Dondero doesn’t just want Gage to give up the CEO’s role; he wants him out entirely, demanding that he resign as chairman, and calling on the board to name former chairman and CEO Laurence Korn to succeed him. In addition, Highland wants an independent director named to fill a vacancy on the board, and for the process of selling the company to be expedited.

“We have attempted to, and will remain available to, discuss the recommendations put forth in this letter,” Dondero assured. But he went on, “That said, we believe the time for dialogue has ended and encourage each of you to honor your fiduciary obligations to the company and its shareholders by expeditiously implementing our recommendations in order to protect shareholder value.”


In Depth

GSAM's Papagiannis: Liquid Alternatives For The Long Run

Apr 21 2017 | 8:44pm ET

Interest in liquid alternatives cooled a bit last year amid a broad shift in investor...

Lifestyle

Aston Martin Returns To Debt Market As DB11 Drives Turnaround

Mar 31 2017 | 5:21pm ET

James Bond’s preferred carmaker is returning to the public debt markets for the...

Guest Contributor

Debunking Conventional Investment Wisdom (Part II)

Apr 17 2017 | 5:56pm ET

The alternative investment industry is currently replete with buzzwords around data...

 

From the current issue of